S. Rondot

发表

Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.

M. Kreissl, K. Schmid, H. Dralle, 2013, Thyroid : official journal of the American Thyroid Association.

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.

H. Buhr, H. Dralle, N. Senninger, 2006, European journal of endocrinology.

[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].

M. Büchler, F. Raue, G. Leidig-Bruckner, 2011, Deutsche medizinische Wochenschrift.

Epitopes fused to F-pilin are incorporated into functional recombinant pili.

S. Wiemann, M. Little, F. Breitling, 1998, Journal of molecular biology.

Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC

F. Raue, K. Frank‐Raue, S. Rondot, 2010, Molecular and Cellular Endocrinology.

Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation

J. Bojunga, C. Welsch, E. Schulze, 2022, BMC Endocrine Disorders.

Clinical utility gene card for: multiple endocrine neoplasia type 2

B. Jarzab, F. Raue, K. Frank‐Raue, 2011, European Journal of Human Genetics.

Change in the spectrum of RET mutations diagnosed between 1994 and 2006.

F. Raue, K. Frank‐Raue, E. Schulze, 2007, Clinical laboratory.

Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma.

B. Pützer, H. Herbst, N. Senninger, 2008, European journal of endocrinology.

Primary hyperparathyroidism as the leading symptom in a patient with a Y791F RET mutation.

S. Baumgartner-Parzer, C. Bieglmayer, H. Vierhapper, 2005, Thyroid : official journal of the American Thyroid Association.

Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.

W. Hoeppner, F. Raue, K. Frank‐Raue, 2005, The Journal of clinical endocrinology and metabolism.

Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation.

F. Waldhauser, W. Waldhäusl, S. Baumgartner-Parzer, 2001, The Journal of clinical endocrinology and metabolism.

Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer

K. Lorenz, H. Dralle, A. Machens, 2012, Clinical endocrinology.

Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.

G. Kayser, J. Seufert, N. Perakakis, 2015, Hormones.

Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype

G. Kayser, J. Seufert, N. Perakakis, 2016, Hormones.

[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].

F. Raue, K. Frank‐Raue, W. Meng, 2003, Deutsche Medizinische Wochenschrift.

A helper phage to improve single-chain antibody presentation in phage display

J. Koch, F. Breitling, S. Dübel, 2001, Nature Biotechnology.

New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.

J. Döhring, H. Dralle, F. Raue, 2009, Experimental and clinical endocrinology & diabetes.

Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer

K. Lorenz, H. Dralle, A. Machens, 2012, Clinical endocrinology.